Mice lacking CD200R1 show absence of suppression of lipopolysaccharide- induced tumor necrosis factor-α and mixed leukocyte culture responses by CD200

Transplantation

Volumn 84, Issue 2, 2007, Pages 251-257

  Boudakov, Ivo ^a   Liu, Jian ^a   Fan, Na ^a   Gulay, Pelin ^a   Wong, Karrie ^a   Gorczynski, Reg M ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MaRS Tower ^*  (Canada)

Author keywords

CD200; Immunosuppression; Knockout mice; Tolerance

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR; CD200 RECEPTOR 1 ANTIBODY; CD200 RECEPTOR 1 PROTEIN; CD200FC; IMMUNOGLOBULIN G2A ANTIBODY; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; C57BL 6 MOUSE; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; EXON; FEMALE; GENE ACTIVATION; GENE INTERACTION; GENE REPRESSION; GENETIC TRANSFORMATION; GENOME; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOREGULATION; MIXED LEUKOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, SURFACE; BLOTTING, SOUTHERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN TRANSPLANTATION; SPLEEN; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547630099     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269795.04592.cc     Document Type: Article

References (22)

1. Harada H, Salama AD, Sho M, et al. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 2003; 112: 234.
2. Fujii SI, Liu K, Smith C, Bonito AJ, Steinman RM. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004; 199: 1607.
3. Dong C, Juedes AE, Temann UA, et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001; 409: 97.
4. Rothstein DM, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 2003; 196: 85.
5. Parry RV, Chemnitz JM, Frauwirth KA, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005; 25: 9543.
6. Gorczynski RM, Chen Z, Lee L, Yu K, Hua J. Anti-CD200R ameliorates collagen-induced arthritis in mice. Clin Immunol 2002; 104: 256.
7. Minas K, Liversidge J. Is the CD200/CD200 receptor interaction more than just a myeloid cell lnhibitory signal? Crit Rev Immunol 2006; 26: 213.
8. Cherwinski HM, Murphy CA, Joyce BL, et al. The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J Immunol, 2005; 174: 1348.
9. Colonna M. TREMS in the immune system and beyond. Nature Rev Immunol 2003; 3: 445.
10. Gorczynski R, Chen ZQ, Kai Y, Lee L, Wong S, Marsden PA. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol 2004; 172: 7744.
11. Gorczynski RM, Chen Z, Clark DA, et al. Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the fetomaternal interface. Am J Reprod Immunol 2004; 52: 147.
12. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000; 290: 1768.
13. Zhang SL, Cherwinski H, Sedgwick JD, Phillips JH. Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol 2004; 173: 6786.
14. + Treg stimulated by anti-CD200R2 derived dendritic cells suppress MLCs and skin graft rejection. Transplantation 2005; 81: 1027.
15. Gorczynski RM. Evidence for an immunoregulatory role of OX2 with its counter ligand (OX2L) in regulation of transplant rejection, fetal loss, autoimmunity and tumor growth. Arch Immunol Therap Experim 2001; 49: 303.
16. Gorczynski RM, Cattral MS, Chen ZG, et al. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol 1999; 163: 1654.
17. Gorczynski RM, Yu K, Clark D. Receptor engagement on cells expressing a ligand for the tolerance- inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo. J Immunol 2000; 165: 4854.
18. Hatherley D, Cherwinski HM, Moshref M, Barclay AN. Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor. J Immunol 2005; 175: 2469.
19. Gorczynski RM. Transplant tolerance modifying antibody, to CD200 receptor, but not CD200, alters cytokine production profile from stimulated macrophages. Eur J Immunol 2001; 31: 2331.
20. Shichijo S, Keicho N, Long HT, et al. Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long-lasting immunity. Tissue Antigen 2004; 64: 600.
21. Zhang S, Phillips JH. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. J Leuk Biol 2006; 79: 1.
22. Gorczynski RM, Hadidi S, Yu G, Clark DA. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol 2002; 48: 18.